Skip to main content
Clinical Trials/NL-OMON37354
NL-OMON37354
Completed
Not Applicable

nravelling brain mechanisms of cognitive impairment in breast cancer patients during adjuvant endocrine treatment - Effects of hormonal treatment for breast cancer on brain and cognition

Radboud Universiteit Nijmegen0 sites150 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
breast cancer
Sponsor
Radboud Universiteit Nijmegen
Enrollment
150
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Women of age \* 18 years.
  • \* Histologically/cytologically confirmed adenocarcinoma of the breast followed by intended curative surgery and if indicated, also radiotherapy and chemotherapy.
  • \* ER \+ and/or PgR \+ receptor status.
  • \* Indication for treatment with tamoxifen or anastrozole according to the Dutch guidelines.
  • \* Disease\-free, as defined by the absence of somatic disease activity parameters.
  • \* Accessible for follow\-up for duration of study.
  • \* Karnofsky 80\-100\.
  • \* Written informed consent.

Exclusion Criteria

  • \* Palliative treatment or inflammatory breast cancer .
  • \* Evidence of distant metastasis (M1\).
  • \* Concomitant or previous malignancies except for adequately treated carcinoma in situ of the uterine cervix or basal squamous cell carcinoma of the skin.
  • \* Hormone Replacement Therapy for treatment of menopausal symptoms, not stopped at least 4 weeks prior to inclusion in the study.
  • \* Current psychological or psychiatric treatment.
  • \* Treatment with anti\-depressive drugs, anti\-epileptic drugs, benzodiazepines.
  • \* Insufficient command of the Dutch language to fill out questionnaires.
  • \* Contra\-indication for MR examinations (e.g. claustrophobia).

Outcomes

Primary Outcomes

Not specified

Similar Trials